Larson Financial Group
IMNM icon

Larson Financial Group’s Immunome IMNM Stock Holding History

Larson Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.51K Hold
70
– – ﹤0.01% 3299
2026
Q2 		$1.48K Sell
70
-15
-18% -$321 ﹤0.01% 3197
2026
Q1 		$1.86K Buy
85
+2
+2% +$45 ﹤0.01% 2978
2025
Q4 		$1.78K Sell
83
-7
-8% -$123 ﹤0.01% 2805
2025
Q3 		$1.05K Buy
90
+23
+34% +$229 ﹤0.01% 2905
2025
Q2 		$623 Buy
+67
New +$549 ﹤0.01% 2798

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Alerus Financial
Alerus Financial Grand Forks, North Dakota $2.27B AUM 22.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Larson Financial Group's IMNM Position: Q3 2026 in Review

Larson Financial Group held its Immunome (IMNM) position steady in Q3 2026 at 70 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3299.

Larson Financial Group first reported a position in IMNM in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.86K in Q1 2026. 84 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Larson Financial Group held 70 shares of Immunome worth $1.51K as of Q3 2026.
  • Larson Financial Group left its Immunome share count unchanged in Q3 2026.
  • Immunome made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3299 holding.
  • Larson Financial Group first reported a position in Immunome in Q2 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Immunome position peaked at $1.86K in Q1 2026.
  • 84 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.